Synergistic interactions between vorinostat and sorafenib in chronic myelogenous leukemia cells involve Mcl-1 and p21CIP1 down-regulation
Clinical Cancer Research (2007) - Comment
pubmed: 17634558  doi: 10.1158/1078-0432.ccr-07-0835  issn: 1078-0432  issn: 1557-3265 

Girija Dasmahapatra, Nitin Yerram, Yun Dai, Paul Dent, Steven Grant